ibio-600
·Code: IBIO-600
ibio-600: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| iBio, Inc. (IBIO) | Phase 1 |
Clinical Trials (1)
A Phase I, First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IBIO-600 in Overweight or Obese Adult Participants (IBIO-600-CT001).
Frequently asked questions
Who is developing ibio-600?
ibio-600 is being developed by iBio, Inc..
How many clinical trials involve ibio-600?
BioSniper tracks 1 clinical trial involving ibio-600.
Get deeper analysis on ibio-600
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis